Global Nanopharmaceuticals Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 164773
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Nanopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nanopharmaceuticals size is estimated to be xx million in 2021 from USD 28190 million in 2020, with a change of XX% between 2020 and 2021. The global Nanopharmaceuticals market size is expected to grow at a CAGR of 12.4% for the next five years.

Market segmentation

Nanopharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Liposomes

Polymeric Micelles

Solid Lipid Nanoparticles

Microemulsion and Nnanoemulsion

Nanosuspension

Market segment by Application can be divided into

Cancer and Tumor

Autoimmune Disorders

Inflammation

Others

The key market players for global Nanopharmaceuticals market are listed below:

Merck

Pfizer

Novartis

Abbott

GlaxoSmithKline

Roche

Sanofi

Eli Lilly

Astrazeneca

Johnson & Johnson

Celgene

Novavax

Stryker

Gilead Sciences

OSI Pharmaceuticals

Kadmon Pharmaceuticals

Samyang Biopharm

Mitsubishi Pharma

Kaken Pharmaceutical

Selecta Biosciences

Par Pharmaceutical

Cerulean Pharma

Navidea Biopharmaceuticals

Lummy

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Nanopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Nanopharmaceuticals, with price, sales, revenue and global market share of Nanopharmaceuticals in 2018 and 2019.

Chapter 3, the Nanopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Nanopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Nanopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Nanopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Nanopharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Nanopharmaceuticals Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Liposomes

1.2.3 Polymeric Micelles

1.2.4 Solid Lipid Nanoparticles

1.2.5 Microemulsion and Nnanoemulsion

1.2.6 Nanosuspension

1.3 Market Analysis by Application

1.3.1 Overview: Global Nanopharmaceuticals Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Cancer and Tumor

1.3.3 Autoimmune Disorders

1.3.4 Inflammation

1.3.5 Others

1.4 Global Nanopharmaceuticals Market Size & Forecast

1.4.1 Global Nanopharmaceuticals Sales in Value (2016-2026))

1.4.2 Global Nanopharmaceuticals Sales in Volume (2016-2026)

1.4.3 Global Nanopharmaceuticals Price by Type (2016-2026) & (USD/MT)

1.5 Global Nanopharmaceuticals Production Capacity Analysis

1.5.1 Global Nanopharmaceuticals Total Production Capacity (2016-2026)

1.5.2 Global Nanopharmaceuticals Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Nanopharmaceuticals Market Drivers

1.6.2 Nanopharmaceuticals Market Restraints

1.6.3 Nanopharmaceuticals Trends Analysis

2 Manufacturers Profiles

2.1 Merck

2.1.1 Merck Details

2.1.2 Merck Major Business

2.1.3 Merck Nanopharmaceuticals Product and Services

2.1.4 Merck Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Pfizer

2.2.1 Pfizer Details

2.2.2 Pfizer Major Business

2.2.3 Pfizer Nanopharmaceuticals Product and Services

2.2.4 Pfizer Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Novartis

2.3.1 Novartis Details

2.3.2 Novartis Major Business

2.3.3 Novartis Nanopharmaceuticals Product and Services

2.3.4 Novartis Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Abbott

2.4.1 Abbott Details

2.4.2 Abbott Major Business

2.4.3 Abbott Nanopharmaceuticals Product and Services

2.4.4 Abbott Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 GlaxoSmithKline

2.5.1 GlaxoSmithKline Details

2.5.2 GlaxoSmithKline Major Business

2.5.3 GlaxoSmithKline Nanopharmaceuticals Product and Services

2.5.4 GlaxoSmithKline Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Roche

2.6.1 Roche Details

2.6.2 Roche Major Business

2.6.3 Roche Nanopharmaceuticals Product and Services

2.6.4 Roche Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Sanofi

2.7.1 Sanofi Details

2.7.2 Sanofi Major Business

2.7.3 Sanofi Nanopharmaceuticals Product and Services

2.7.4 Sanofi Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Eli Lilly

2.8.1 Eli Lilly Details

2.8.2 Eli Lilly Major Business

2.8.3 Eli Lilly Nanopharmaceuticals Product and Services

2.8.4 Eli Lilly Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Astrazeneca

2.9.1 Astrazeneca Details

2.9.2 Astrazeneca Major Business

2.9.3 Astrazeneca Nanopharmaceuticals Product and Services

2.9.4 Astrazeneca Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Johnson & Johnson

2.10.1 Johnson & Johnson Details

2.10.2 Johnson & Johnson Major Business

2.10.3 Johnson & Johnson Nanopharmaceuticals Product and Services

2.10.4 Johnson & Johnson Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Celgene

2.11.1 Celgene Details

2.11.2 Celgene Major Business

2.11.3 Celgene Nanopharmaceuticals Product and Services

2.11.4 Celgene Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Novavax

2.12.1 Novavax Details

2.12.2 Novavax Major Business

2.12.3 Novavax Nanopharmaceuticals Product and Services

2.12.4 Novavax Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Stryker

2.13.1 Stryker Details

2.13.2 Stryker Major Business

2.13.3 Stryker Nanopharmaceuticals Product and Services

2.13.4 Stryker Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Gilead Sciences

2.14.1 Gilead Sciences Details

2.14.2 Gilead Sciences Major Business

2.14.3 Gilead Sciences Nanopharmaceuticals Product and Services

2.14.4 Gilead Sciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 OSI Pharmaceuticals

2.15.1 OSI Pharmaceuticals Details

2.15.2 OSI Pharmaceuticals Major Business

2.15.3 OSI Pharmaceuticals Nanopharmaceuticals Product and Services

2.15.4 OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.16 Kadmon Pharmaceuticals

2.16.1 Kadmon Pharmaceuticals Details

2.16.2 Kadmon Pharmaceuticals Major Business

2.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Product and Services

2.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.17 Samyang Biopharm

2.17.1 Samyang Biopharm Details

2.17.2 Samyang Biopharm Major Business

2.17.3 Samyang Biopharm Nanopharmaceuticals Product and Services

2.17.4 Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.18 Mitsubishi Pharma

2.18.1 Mitsubishi Pharma Details

2.18.2 Mitsubishi Pharma Major Business

2.18.3 Mitsubishi Pharma Nanopharmaceuticals Product and Services

2.18.4 Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.19 Kaken Pharmaceutical

2.19.1 Kaken Pharmaceutical Details

2.19.2 Kaken Pharmaceutical Major Business

2.19.3 Kaken Pharmaceutical Nanopharmaceuticals Product and Services

2.19.4 Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.20 Selecta Biosciences

2.20.1 Selecta Biosciences Details

2.20.2 Selecta Biosciences Major Business

2.20.3 Selecta Biosciences Nanopharmaceuticals Product and Services

2.20.4 Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.21 Par Pharmaceutical

2.21.1 Par Pharmaceutical Details

2.21.2 Par Pharmaceutical Major Business

2.21.3 Par Pharmaceutical Nanopharmaceuticals Product and Services

2.21.4 Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.22 Cerulean Pharma

2.22.1 Cerulean Pharma Details

2.22.2 Cerulean Pharma Major Business

2.22.3 Cerulean Pharma Nanopharmaceuticals Product and Services

2.22.4 Cerulean Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.23 Navidea Biopharmaceuticals

2.23.1 Navidea Biopharmaceuticals Details

2.23.2 Navidea Biopharmaceuticals Major Business

2.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Product and Services

2.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.24 Lummy

2.24.1 Lummy Details

2.24.2 Lummy Major Business

2.24.3 Lummy Nanopharmaceuticals Product and Services

2.24.4 Lummy Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Nanopharmaceuticals Sales by Manufacturer

3.1 Global Nanopharmaceuticals Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Nanopharmaceuticals Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Nanopharmaceuticals

3.4 Market Concentration Rate

3.4.1 Top 3 Nanopharmaceuticals Manufacturer Market Share

3.4.2 Top 6 Nanopharmaceuticals Manufacturer Market Share

3.5 Global Nanopharmaceuticals Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Nanopharmaceuticals Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Nanopharmaceuticals Market Size by Region

4.1.1 Global Nanopharmaceuticals Sales in Volume by Region (2016-2026)

4.1.2 Global Nanopharmaceuticals Revenue by Region (2016-2026)

4.2 North America Nanopharmaceuticals Revenue (2016-2026)

4.3 Europe Nanopharmaceuticals Revenue (2016-2026)

4.4 Asia-Pacific Nanopharmaceuticals Revenue (2016-2026)

4.5 South America Nanopharmaceuticals Revenue (2016-2026)

4.6 Middle East and Africa Nanopharmaceuticals Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Nanopharmaceuticals Sales in Volume by Type (2016-2026)

5.2 Global Nanopharmaceuticals Revenue by Type (2016-2026)

5.3 Global Nanopharmaceuticals Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Nanopharmaceuticals Sales in Volume by Application (2016-2026)

6.2 Global Nanopharmaceuticals Revenue by Application (2016-2026)

6.3 Global Nanopharmaceuticals Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Nanopharmaceuticals Sales by Type (2016-2026)

7.2 North America Nanopharmaceuticals Sales by Application (2016-2026)

7.3 North America Nanopharmaceuticals Market Size by Country

7.3.1 North America Nanopharmaceuticals Sales in Volume by Country (2016-2026)

7.3.2 North America Nanopharmaceuticals Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Nanopharmaceuticals Sales by Type (2016-2026)

8.2 Europe Nanopharmaceuticals Sales by Application (2016-2026)

8.3 Europe Nanopharmaceuticals Market Size by Country

8.3.1 Europe Nanopharmaceuticals Sales in Volume by Country (2016-2026)

8.3.2 Europe Nanopharmaceuticals Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Nanopharmaceuticals Sales by Type (2016-2026)

9.2 Asia-Pacific Nanopharmaceuticals Sales by Application (2016-2026)

9.3 Asia-Pacific Nanopharmaceuticals Market Size by Region

9.3.1 Asia-Pacific Nanopharmaceuticals Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Nanopharmaceuticals Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Nanopharmaceuticals Sales by Type (2016-2026)

10.2 South America Nanopharmaceuticals Sales by Application (2016-2026)

10.3 South America Nanopharmaceuticals Market Size by Country

10.3.1 South America Nanopharmaceuticals Sales in Volume by Country (2016-2026)

10.3.2 South America Nanopharmaceuticals Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Nanopharmaceuticals Sales by Type (2016-2026)

11.2 Middle East & Africa Nanopharmaceuticals Sales by Application (2016-2026)

11.3 Middle East & Africa Nanopharmaceuticals Market Size by Country

11.3.1 Middle East & Africa Nanopharmaceuticals Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Nanopharmaceuticals Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Nanopharmaceuticals Typical Distributors

12.3 Nanopharmaceuticals Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Nanopharmaceuticals Revenue by Type, (USD Million), 2021-2026

Table 2. Global Nanopharmaceuticals Revenue by Application, (USD Million), 2021-2026

Table 3. Merck Basic Information, Manufacturing Base and Competitors

Table 4. Merck Major Business

Table 5. Merck Nanopharmaceuticals Product and Services

Table 6. Merck Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Pfizer Basic Information, Manufacturing Base and Competitors

Table 8. Pfizer Major Business

Table 9. Pfizer Nanopharmaceuticals Product and Services

Table 10. Pfizer Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Novartis Basic Information, Manufacturing Base and Competitors

Table 12. Novartis Major Business

Table 13. Novartis Nanopharmaceuticals Product and Services

Table 14. Novartis Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Abbott Basic Information, Manufacturing Base and Competitors

Table 16. Abbott Major Business

Table 17. Abbott Nanopharmaceuticals Product and Services

Table 18. Abbott Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table 20. GlaxoSmithKline Major Business

Table 21. GlaxoSmithKline Nanopharmaceuticals Product and Services

Table 22. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Roche Basic Information, Manufacturing Base and Competitors

Table 24. Roche Major Business

Table 25. Roche Nanopharmaceuticals Product and Services

Table 26. Roche Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Sanofi Basic Information, Manufacturing Base and Competitors

Table 28. Sanofi Major Business

Table 29. Sanofi Nanopharmaceuticals Product and Services

Table 30. Sanofi Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors

Table 32. Eli Lilly Major Business

Table 33. Eli Lilly Nanopharmaceuticals Product and Services

Table 34. Eli Lilly Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Astrazeneca Basic Information, Manufacturing Base and Competitors

Table 36. Astrazeneca Major Business

Table 37. Astrazeneca Nanopharmaceuticals Product and Services

Table 38. Astrazeneca Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table 40. Johnson & Johnson Major Business

Table 41. Johnson & Johnson Nanopharmaceuticals Product and Services

Table 42. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Celgene Basic Information, Manufacturing Base and Competitors

Table 44. Celgene Major Business

Table 45. Celgene Nanopharmaceuticals Product and Services

Table 46. Celgene Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Novavax Basic Information, Manufacturing Base and Competitors

Table 48. Novavax Major Business

Table 49. Novavax Nanopharmaceuticals Product and Services

Table 50. Novavax Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Stryker Basic Information, Manufacturing Base and Competitors

Table 52. Stryker Major Business

Table 53. Stryker Nanopharmaceuticals Product and Services

Table 54. Stryker Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Gilead Sciences Basic Information, Manufacturing Base and Competitors

Table 56. Gilead Sciences Major Business

Table 57. Gilead Sciences Nanopharmaceuticals Product and Services

Table 58. Gilead Sciences Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 60. OSI Pharmaceuticals Major Business

Table 61. OSI Pharmaceuticals Nanopharmaceuticals Product and Services

Table 62. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. Kadmon Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 64. Kadmon Pharmaceuticals Major Business

Table 65. Kadmon Pharmaceuticals Nanopharmaceuticals Product and Services

Table 66. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 67. Samyang Biopharm Basic Information, Manufacturing Base and Competitors

Table 68. Samyang Biopharm Major Business

Table 69. Samyang Biopharm Nanopharmaceuticals Product and Services

Table 70. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 71. Mitsubishi Pharma Basic Information, Manufacturing Base and Competitors

Table 72. Mitsubishi Pharma Major Business

Table 73. Mitsubishi Pharma Nanopharmaceuticals Product and Services

Table 74. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 75. Kaken Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 76. Kaken Pharmaceutical Major Business

Table 77. Kaken Pharmaceutical Nanopharmaceuticals Product and Services

Table 78. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 79. Selecta Biosciences Basic Information, Manufacturing Base and Competitors

Table 80. Selecta Biosciences Major Business

Table 81. Selecta Biosciences Nanopharmaceuticals Product and Services

Table 82. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 83. Par Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 84. Par Pharmaceutical Major Business

Table 85. Par Pharmaceutical Nanopharmaceuticals Product and Services

Table 86. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 87. Cerulean Pharma Basic Information, Manufacturing Base and Competitors

Table 88. Cerulean Pharma Major Business

Table 89. Cerulean Pharma Nanopharmaceuticals Product and Services

Table 90. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 91. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 92. Navidea Biopharmaceuticals Major Business

Table 93. Navidea Biopharmaceuticals Nanopharmaceuticals Product and Services

Table 94. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 95. Lummy Basic Information, Manufacturing Base and Competitors

Table 96. Lummy Major Business

Table 97. Lummy Nanopharmaceuticals Product and Services

Table 98. Lummy Nanopharmaceuticals Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 99. Global Nanopharmaceuticals Sales by Manufacturer (2019-2021e) & (K MT)

Table 100. Global Nanopharmaceuticals Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 101. Market Position of Manufacturers in Nanopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 102. Global Nanopharmaceuticals Production Capacity by Company, (K MT): 2020 VS 2021

Table 103. Head Office and Nanopharmaceuticals Production Site of Key Manufacturer

Table 104. Nanopharmaceuticals New Entrant and Capacity Expansion Plans

Table 105. Nanopharmaceuticals Mergers & Acquisitions in the Past Five Years

Table 106. Global Nanopharmaceuticals Sales by Region (2016-2021e) & (K MT)

Table 107. Global Nanopharmaceuticals Sales by Region (2021-2026) & (K MT)

Table 108. Global Nanopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)

Table 109. Global Nanopharmaceuticals Revenue by Region (2021-2026) & (USD Million)

Table 110. Global Nanopharmaceuticals Sales by Type (2016-2021e) & (K MT)

Table 111. Global Nanopharmaceuticals Sales by Type (2021-2026) & (K MT)

Table 112. Global Nanopharmaceuticals Revenue by Type (2016-2021e) & (USD Million)

Table 113. Global Nanopharmaceuticals Revenue by Type (2021-2026) & (USD Million)

Table 114. Global Nanopharmaceuticals Price by Type (2016-2021e) & (USD/MT)

Table 115. Global Nanopharmaceuticals Price by Type (2021-2026) & (USD/MT)

Table 116. Global Nanopharmaceuticals Sales by Application (2016-2021e) & (K MT)

Table 117. Global Nanopharmaceuticals Sales by Application (2021-2026) & (K MT)

Table 118. Global Nanopharmaceuticals Revenue by Application (2016-2021e) & (USD Million)

Table 119. Global Nanopharmaceuticals Revenue by Application (2021-2026) & (USD Million)

Table 120. Global Nanopharmaceuticals Price by Application (2016-2021e) & (USD/MT)

Table 121. Global Nanopharmaceuticals Price by Application (2021-2026) & (USD/MT)

Table 122. North America Nanopharmaceuticals Sales by Country (2016-2021e) & (K MT)

Table 123. North America Nanopharmaceuticals Sales by Country (2021-2026) & (K MT)

Table 124. North America Nanopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 125. North America Nanopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 126. North America Nanopharmaceuticals Sales by Type (2016-2021e) & (K MT)

Table 127. North America Nanopharmaceuticals Sales by Type (2021-2026) & (K MT)

Table 128. North America Nanopharmaceuticals Sales by Application (2016-2021e) & (K MT)

Table 129. North America Nanopharmaceuticals Sales by Application (2021-2026) & (K MT)

Table 130. Europe Nanopharmaceuticals Sales by Country (2016-2021e) & (K MT)

Table 131. Europe Nanopharmaceuticals Sales by Country (2021-2026) & (K MT)

Table 132. Europe Nanopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 133. Europe Nanopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 134. Europe Nanopharmaceuticals Sales by Type (2016-2021e) & (K MT)

Table 135. Europe Nanopharmaceuticals Sales by Type (2021-2026) & (K MT)

Table 136. Europe Nanopharmaceuticals Sales by Application (2016-2021e) & (K MT)

Table 137. Europe Nanopharmaceuticals Sales by Application (2021-2026) & (K MT)

Table 138. Asia-Pacific Nanopharmaceuticals Sales by Region (2016-2021e) & (K MT)

Table 139. Asia-Pacific Nanopharmaceuticals Sales by Region (2021-2026) & (K MT)

Table 140. Asia-Pacific Nanopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)

Table 141. Asia-Pacific Nanopharmaceuticals Revenue by Region (2021-2026) & (USD Million)

Table 142. Asia-Pacific Nanopharmaceuticals Sales by Type (2016-2021e) & (K MT)

Table 143. Asia-Pacific Nanopharmaceuticals Sales by Type (2021-2026) & (K MT)

Table 144. Asia-Pacific Nanopharmaceuticals Sales by Application (2016-2021e) & (K MT)

Table 145. Asia-Pacific Nanopharmaceuticals Sales by Application (2021-2026) & (K MT)

Table 146. South America Nanopharmaceuticals Sales by Country (2016-2021e) & (K MT)

Table 147. South America Nanopharmaceuticals Sales by Country (2021-2026) & (K MT)

Table 148. South America Nanopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 149. South America Nanopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 150. South America Nanopharmaceuticals Sales by Type (2016-2021e) & (K MT)

Table 151. South America Nanopharmaceuticals Sales by Type (2021-2026) & (K MT)

Table 152. South America Nanopharmaceuticals Sales by Application (2016-2021e) & (K MT)

Table 153. South America Nanopharmaceuticals Sales by Application (2021-2026) & (K MT)

Table 154. Middle East & Africa Nanopharmaceuticals Sales by Country (2016-2021e) & (K MT)

Table 155. Middle East & Africa Nanopharmaceuticals Sales by Country (2021-2026) & (K MT)

Table 156. Middle East & Africa Nanopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 157. Middle East & Africa Nanopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 158. Middle East & Africa Nanopharmaceuticals Sales by Type (2016-2021e) & (K MT)

Table 159. Middle East & Africa Nanopharmaceuticals Sales by Type (2021-2026) & (K MT)

Table 160. Middle East & Africa Nanopharmaceuticals Sales by Application (2016-2021e) & (K MT)

Table 161. Middle East & Africa Nanopharmaceuticals Sales by Application (2021-2026) & (K MT)

Table 162. Direct Channel Pros & Cons

Table 163. Indirect Channel Pros & Cons

Table 164. Nanopharmaceuticals Typical Distributors

Table 165. Nanopharmaceuticals Typical Customers

List of Figures

Figure 1. Nanopharmaceuticals Picture

Figure 2. Global Nanopharmaceuticals Sales Market Share by Type in 2020

Figure 3. Liposomes

Figure 4. Polymeric Micelles

Figure 5. Solid Lipid Nanoparticles

Figure 6. Microemulsion and Nnanoemulsion

Figure 7. Nanosuspension

Figure 8. Global Nanopharmaceuticals Sales Market Share by Application in 2020

Figure 9. Cancer and Tumor

Figure 10. Autoimmune Disorders

Figure 11. Inflammation

Figure 12. Others

Figure 13. Global Nanopharmaceuticals Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026

Figure 14. Global Nanopharmaceuticals Market Size and Forecast (2016-2026) & (USD Million)

Figure 15. Global Nanopharmaceuticals Sales (2016-2026) & (K MT)

Figure 16. Global Nanopharmaceuticals Price by Type (2016-2026) & (USD/MT)

Figure 17. Global Nanopharmaceuticals Production Capacity (2016-2026) & (K MT)

Figure 18. Global Nanopharmaceuticals Production Capacity by Geographic Region: 2020 VS 2021

Figure 19. Nanopharmaceuticals Market Drivers

Figure 20. Nanopharmaceuticals Market Restraints

Figure 21. Nanopharmaceuticals Market Trends

Figure 22. Global Nanopharmaceuticals Sales Market Share by Manufacturer in 2020

Figure 23. Global Nanopharmaceuticals Revenue Market Share by Manufacturer in 2020

Figure 24. Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 25. Top 3 Nanopharmaceuticals Manufacturer (Revenue) Market Share in 2020

Figure 26. Top 6 Nanopharmaceuticals Manufacturer (Revenue) Market Share in 2020

Figure 27. Global Nanopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 28. Global Nanopharmaceuticals Revenue Market Share by Region (2016-2026)

Figure 29. North America Nanopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 30. Europe Nanopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 31. Asia-Pacific Nanopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 32. South America Nanopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 33. Middle East & Africa Nanopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 34. Global Nanopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 35. Global Nanopharmaceuticals Revenue Market Share by Type (2016-2026)

Figure 36. Global Nanopharmaceuticals Price by Type (2016-2026) & (USD/MT)

Figure 37. Global Nanopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 38. Global Nanopharmaceuticals Revenue Market Share by Application (2016-2026)

Figure 39. Global Nanopharmaceuticals Price by Application (2016-2026) & (USD/MT)

Figure 40. North America Nanopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 41. North America Nanopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 42. North America Nanopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 43. North America Nanopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 44. United States Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Canada Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Mexico Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Europe Nanopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 48. Europe Nanopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 49. Europe Nanopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 50. Europe Nanopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 51. Germany Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. France Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. United Kingdom Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Russia Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Italy Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Asia-Pacific Nanopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 57. Asia-Pacific Nanopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 58. Asia-Pacific Nanopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 59. Asia-Pacific Nanopharmaceuticals Revenue Market Share by Region (2016-2026)

Figure 60. China Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Japan Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Korea Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. India Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Southeast Asia Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Australia Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South America Nanopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 67. South America Nanopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 68. South America Nanopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 69. South America Nanopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 70. Brazil Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Argentina Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Middle East & Africa Nanopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 73. Middle East & Africa Nanopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 74. Middle East & Africa Nanopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 75. Middle East & Africa Nanopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Egypt Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Saudi Arabia Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. South Africa Nanopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Sales Channel: Direct Channel vs Indirect Channel

Figure 81. Methodology

Figure 82. Research Process and Data Source